Atienza Mateo, B., Pato, E., Díaz Valle, D., López Longo, F. J., & Blanco, R. (2019). Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases.
Citación estilo ChicagoAtienza Mateo, Belén, Esperanza Pato, David Díaz Valle, Francisco Javier López Longo, y Ricardo Blanco. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis Due to Behçet's Disease: National Multicenter Study of 177 Cases. 2019.
Cita MLAAtienza Mateo, Belén, et al. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis Due to Behçet's Disease: National Multicenter Study of 177 Cases. 2019.
Precaución: Estas citas no son 100% exactas.